Please try another search
Sinotherapeutics Inc., a specialty pharmaceutical company, develops generic and formulation products in China. It offers posaconazole delayed-release tablets, ursodeoxycholic acid capsules, bupropion hydrochloride extended-release tablets, paroxetine extended-release tablets, sevelamer carbonate tablets, and propafenone hydrochloride extended-release capsules. The company provides CRO/CDMO services including pre-formulation study, formulation and process development, clinical sample manufacturing, NDA registration batch manufacturing, quality standard establishment, and regulatory dossier document preparation and submission. Sinotherapeutics Inc. was founded in 2012 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Jun Ye | 51 | - | Chairman |
Zhijie Liu | 61 | - | Independent Director |
Yong Lv | 65 | - | Independent Director |
Hui Zhang | 41 | - | Employee Representative Supervisor |
Shengwan Jian | 65 | - | Director |
Jun Zhang | 51 | - | Independent Director |
Siyu Shen | 41 | - | Director |
Xiaoming Ying | 55 | - | Director |
Gu Maojian | 71 | - | Director |
Yan Qing Wang | 45 | - | Chairman of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review